The story of the erectile dysfunction drug presents a challenging picture for those considering investment. While the initial launch generated massive returns, the lapse of its intellectual property protection opened https://bookmarkstime.com/story22343244/sildenafil-and-the-pharmaceutical-industry-a-precarious-investment